HOME >> BIOLOGY >> NEWS
Radical approach to cardiac resynchronization shows promise

Correcting the timing of heart contractions through cardiac resynchronization therapy can be a lifesaver for people with advanced heart failure. But the procedure, as it is done today, fails in about 15 percent of patients.

Using a minimally invasive approach that may startle heart specialists, a medical-student researcher developed a technique that--at least in pigs--overcomes the procedure's main shortcomings. Steven Mickelsen, a third-year medical student at the University of New Mexico School of Medicine, performed the research during a year away from medical school as a Howard Hughes Medical Institute-National Institutes of Health research scholar at the National Heart, Lung, and Blood Institute.

Proper timing of the pumping action between the lower chambers of the heart, which send blood to the lungs and the rest of the body, is important for the heart to work effectively. When this timing goes awry in patients with heart failure, implantation of a cardiac resynchronization device can help.

A critical step in cardiac resynchronization therapy is the placing of leads--thin wires that resynchronize the beating of the left and right ventricles--onto the heart itself. The standard approach to lead placement on the left ventricle is through the blood vessel on the heart's surface, which is technically challenging in some patients and limits lead placement to where blood vessels are. A substantial number of cardiac leads fail to work because they are positioned poorly, or they become dislodged. When lead placement fails, the most common next step is open chest surgery to place the lead--an invasive procedure that requires a surgeon and general anesthesia.

Under the mentorship of Elliot McVeigh of NHLBI's Laboratory of Cardiac Energetics, Mickelsen searched for a better way to position the critical leads, testing his new technique in small pigs whose hearts are about the size of a human's. Using a catheter inserted through the pig's jugula
'"/>

Contact: Jennifer Donovan
donovanj@hhmi.org
301-215-8859
Howard Hughes Medical Institute
18-Oct-2005


Page: 1 2 3 4

Related biology news :

1. Radical proposal to speed development of stem cell therapies
2. Researchers use new approach to predict protein function
3. New approach to pulmonary hypertension shows promise
4. Personalized approach to ovarian stimulation achieves high ART pregnancy rates
5. New approaches to endometriosis treatment -- mouse experiments point the way
6. Reconstructing the biology of extinct species: A new approach
7. Screening approach leads to discovery of gene linked to breast cancer
8. In new statistical approach, data decide model
9. Bigelow Laboratory Scientists develop new approach to study marine microbes
10. New understanding of schizophrenia could lead to new treatment approaches
11. Cheaper, better disease treatments expected from faster approach to developing antibodies

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/14/2019)... ... 2019 , ... Join the live session on ... topics in data quality, including:, ,     State of the art ...     Smartphone and wearable based performance measures ,     Data quality analytics ...
(Date:1/10/2019)... ... 10, 2019 , ... When Dr. James L. Sherley, M.D., Ph.D., founder and ... a chapter to the new book Perinatal Stem Cells: Research and Therapy, he knew ... a debilitating secret of stem cell medicine. For more than a half-century, stem ...
(Date:1/8/2019)... ... January 07, 2019 , ... Join industry experts Julie Peacock, Client Services at ... on Thursday, January 17, 2019 at 1pm EST. , This webinar will ... clinical trial process. Featured speakers will also present a case study of a leading ...
Breaking Biology News(10 mins):
(Date:1/7/2019)... ... 07, 2019 , ... Kainos Medicine Inc. today announced that ... code-named "KM-819." KM-819 is an orally active small molecule that is a ... , This Phase 1 randomized, double-blind, placebo-controlled dose-escalation study was to evaluate ...
(Date:1/4/2019)... DIEGO (PRWEB) , ... January 03, 2019 , ... ... at the forefront of oncolytic virus-based immunotherapies for cancer, today announced the founding ... Biotherapeutics to receive critical input and guidance from key leaders in the Immuno-Oncology ...
(Date:12/18/2018)... (PRWEB) , ... December 17, 2018 , ... ... today the second cohort of emerging biosciences ventures invited to participate in the ... education to develop fundable business plans and a professional network. All startups receive ...
(Date:12/13/2018)... , ... December 11, 2018 , ... ... doctors and nurses can use to quickly detect Clostridium difficile (C. diff), a ... heart of a handheld device that can be used onsite in doctor’s offices ...
Breaking Biology Technology:
Cached News: